Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Humans and rhesus macaques share maturation pathways of HIV-1 envelope-reactive V3-glycan bnAb lineages.

Science translational medicine·2026
Same author

TBAF-promoted dephenolative transcarbomylation: direct access to substituted carbamates & thiocarbamates.

Organic & biomolecular chemistry·2026
Same author

Strain-dependent bioactive-lipid interactions govern oxidative stability and antimicrobial functionality in Lentinula edodes.

Food research international (Ottawa, Ont.)·2026
Same author

Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies.

Nature·2026
Same author

Ubiquitin Ligases in pro-atrophic and antiatrophic signaling cascades in muscles.

Molecular biology reports·2026
Same author

Rapid boosting increases germinal center responses to sequential vaccines.

Nature immunology·2026

Related Experiment Video

Updated: Jan 10, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.7K

Consistent Induction of Broadly Neutralizing HIV Antibodies by a Novel Two-Step Mechanism Informs Immunogen Design.

Ashwin N Skelly1, Harry B Gristick2, Hui Li1

  • 1Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA 19104, USA.

Biorxiv : the Preprint Server for Biology
|November 24, 2025
PubMed
Summary

Researchers developed a novel simian-human immunodeficiency virus (SHIV.5MUT) that successfully induced broadly neutralizing antibodies (bNAbs) in macaques. This breakthrough offers a promising animal model for HIV-1 vaccine and cure research.

More Related Videos

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.7K
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

10.9K

Related Experiment Videos

Last Updated: Jan 10, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.7K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

14.7K
Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

10.9K

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Developing effective HIV-1 vaccines and cures is hindered by the absence of suitable outbred animal models.
  • Inducing broadly neutralizing antibodies (bNAbs) consistently and rapidly remains a significant challenge in HIV-1 research.

Purpose of the Study:

  • To design and evaluate a novel simian-human immunodeficiency virus (SHIV.5MUT) for inducing bNAbs in macaques.
  • To establish a reliable outbred animal model for HIV-1 vaccine and cure research.

Main Methods:

  • Engineered an epitope-focused SHIV.5MUT designed to elicit specific antibody responses.
  • Infected macaques with SHIV.5MUT and monitored antibody induction and characteristics.
  • Analyzed the mechanism of bNAb elicitation, including antibody precursor selection and Env coevolution.

Main Results:

  • SHIV.5MUT successfully elicited broad and potent V3-glycan-targeted antibodies in 14 of 22 infected macaques within one year.
  • A novel two-step mechanism involving V1-directed antibodies priming V3-glycan bNAb precursors was identified.
  • The induced rhesus bNAbs exhibited immunogenetic and structural diversity, closely mirroring human bNAbs.

Conclusions:

  • SHIV.5MUT represents a significant advancement, providing a viable outbred animal model for HIV-1 vaccine and cure research.
  • The study elucidates a unique mechanism for bNAb induction, offering a molecular blueprint for future vaccine design.
  • The findings pave the way for developing more effective strategies against HIV-1.